Aug 25 2026 09:17 PM EST

Walmart Faces Sharp Selloff as Slowing U.S. Sales and Margin Pressures Erode Investor Confidence

Walmart Inc. (NYSE: WMT) shares have tumbled nearly 10% over the past five days, following quarterly results that revealed the slowest U.S. comparable sales growth in more than six years and persistent margin headwinds. The selloff, which erased roughly $50 billion in market value, underscores rising investor concerns about the sustainability of Walmart’s growth as cost inflation, regulatory challenges and a weaker U.S. consumer weigh on the retailer’s outlook.

Slowing U.S. Sales and Margin Headwinds Drive Market Reassessment

The immediate catalyst for the selloff was Walmart’s Q2 FY27 earnings report on August 20, which showed U.S. comparable sales rising 2.6%, the weakest growth since 2020 and below analyst expectations of 3–3.5%. While total revenue and adjusted earnings per share exceeded consensus, investors appeared to focus on the deceleration in core U.S. retail, ongoing pharmacy margin pressure, and signs of a more price-sensitive consumer.

Management also struck a cautious tone on the consumer outlook, citing high fuel and food costs, increased price rollbacks (11,000 items in Q2 vs. 7,000 in Q1), and regulatory headwinds in the pharmacy segment related to Medicare drug price negotiations. The net result was a sharp single-day share-price decline of 9.2% on August 21, Walmart’s largest since May 2022.

Earnings Beat Fails to Offset Slowing Comparable Sales and Guidance Concerns

Walmart reported $187.94 billion in Q2 revenue, up 5.9% year-on-year and above consensus estimates. Adjusted EPS of $0.81 also topped forecasts, but net income fell 9.4% to $6.4 billion due in part to equity-investment losses.

Despite raising full-year sales and operating income guidance, management’s Q3 and FY27 EPS projections remain below the most bullish analyst estimates. Q3 EPS is expected at $0.62–$0.64, and full-year adjusted EPS at $2.80–$2.87, compared to consensus of $2.97. The company flagged more than $2 billion in incremental fuel costs for the year and a 125bps headwind from drug pricing regulation.

U.S. in-store traffic rose just 1.5% in the quarter, with spending per visit up only 1.1% year-on-year, down from 2.8% a year earlier. Health and wellness sales were particularly weak, with pharmacy margins pressured by Medicare Fair Price legislation and lower prescription volumes. These trends contributed to analyst price target cuts and several downgrades, with the average target falling to $129.18 from $138.37 pre-earnings.

Macro Pressures, Regulatory Risks and Sector Context

The market reaction also reflects broader macroeconomic and regulatory headwinds. High fuel prices—U.S. gasoline is now above $4.10/gallon—and rising food costs are pressuring household budgets and driving consumers to trade down or reduce basket sizes. U.S. retail sales declined 0.6% in July, the largest monthly drop since May 2025, signaling a pullback in discretionary spending.

Elevated Treasury yields—30-year rates at 5.33%—and inflation near 3.4% are raising the cost of capital and dampening retail sector valuations. Competitive intensity remains high, with Target and Costco reporting better recent U.S. sales trends. Walmart’s forward P/E of 33.8 is elevated relative to its historical median and peers such as Target (17.1) and Dollar General (15.5).

Growth Engines Offset but Do Not Overcome Core Pressures

Walmart’s e-commerce, membership and advertising businesses continue to grow at a strong pace, with global e-commerce sales up 23%, marketplace sales up 52%, and advertising revenue up 38% year-on-year. Walmart+ membership fee revenue rose double digits, reaching all-time highs.

The company is investing in automation, digital fulfillment, and store modernization, and has returned over $7 billion to shareholders in buybacks and dividends this year. However, these growth engines have not been sufficient to offset slowing brick-and-mortar sales and emerging cost pressures in the current macro environment.

Risks and Variables Shaping the Outlook

The principal risks now under scrutiny include the potential for further declines in same-store sales, ongoing pharmacy and regulatory headwinds, and uncertainty around fuel and logistics costs. The benefit from tariff refunds is a one-time factor unlikely to persist into future quarters. Walmart’s high valuation relative to peers increases sensitivity to execution risks and negative earnings revisions.

Walmart’s recent share-price decline reflects a repricing of expectations as investors weigh robust digital growth against slowing core U.S. sales and profit headwinds. The company’s results and cautious outlook have made its shares a barometer for broader consumer resilience and retail sector risk as 2026 enters its final months.